Natural history of aspirin‐induced asthma

There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs. This is a clinical syndrome, called aspirin-induced asthma (AIA), associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction. The natural history and clinical characteristics of this type of asthma were studied. Sixteen clinical centres in 10 European countries provided standardized information to the specially developed patient-oriented database regarding: medical history, physical examination, diagnosis, and treatment. Diagnosis of AIA was based on a typical history, confirmed by positive aspirin provocation tests, carried out in 91% of the patients. A total of 500 patients were enrolled in the study. AIA developed according to a pattern, characterized by a sequence of symptoms. First, persistent rhinitis, appearing at a mean age of 29.7+/-12.5 yrs, then asthma, aspirin intolerance and nasal polyposis appear. The clinical presentation in different European countries was remarkably similar. In females, who outnumbered males by 2.3:1, the onset of symptoms occurred significantly earlier and the disease was more progressive and severe than in males. Atopy, present in approximately a third of patients, led to earlier manifestation of rhinitis and asthma, but not of aspirin intolerance or nasal polyposis. A family history of aspirin intolerance, recorded in 6% of patients, had a less evident effect on the course of the disease than sex or atopy. Fifty one per cent of patients, in addition to inhaled steroids, required chronic systemic corticosteroid therapy at a mean dose of 8 mg prednisone x day(-1). Surprisingly, 15% of patients were unaware of intolerance to aspirin and learnt about it only after having provocation tests performed. All over Europe, aspirin-induced asthma develops in a similar characteristic way. Its course is influenced by sex and the presence of atopy. In half of the patients, asthma is severe, and steroid-dependent. The uniform natural history of aspirin-induced asthma might suggest a common underlying principle.

[1]  A. Szczeklik,et al.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. , 2000, The European respiratory journal.

[2]  K. McDowell,et al.  Pathophysiology of asthma. , 2000, Respiratory care clinics of North America.

[3]  J. Kaprio,et al.  Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. , 1999, International journal of epidemiology.

[4]  J. Mullol,et al.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. , 1999, American journal of respiratory and critical care medicine.

[5]  D. Stevenson,et al.  Aspirin-induced asthma: advances in pathogenesis and management. , 1999, The Journal of allergy and clinical immunology.

[6]  Y. Bariş,et al.  Occurrence of allergic conditions in asthmatics with analgesic intolerance , 1999, Allergy.

[7]  Caroline C. Whitacre,et al.  A Gender Gap in Autoimmunity , 1999, Science.

[8]  B. Wüthrich,et al.  Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop®) , 1998, Allergy.

[9]  L. Dubé,et al.  Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. , 1998, American journal of respiratory and critical care medicine.

[10]  S. Holgate,et al.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. , 1998, The Journal of clinical investigation.

[11]  Tak H. Lee,et al.  LEUKOTRIENES IN ASPIRIN-SENSITIVE ASTHMA , 1998 .

[12]  M. Sanak,et al.  Leukotriene C 4 synthase promoter polymorphism and risk of aspirin-induced asthma , 1997, The Lancet.

[13]  J. Oates,et al.  Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. , 1996, American journal of respiratory and critical care medicine.

[14]  S T Holgate,et al.  Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. , 1996, The Journal of allergy and clinical immunology.

[15]  B. Wüthrich,et al.  Epidemiologic identification of allergic rhinitis , 1996, Allergy.

[16]  R. M. Refini,et al.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.

[17]  A. Szczeklik,et al.  The atopy trait in hypersensitivity to nonsteroidal anti‐inflammatory drugs , 1996, Allergy.

[18]  A. Szczeklik,et al.  Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. , 1995, American journal of respiratory and critical care medicine.

[19]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[20]  P. Abrami,et al.  Anaphylaxie et Idiosyncrasie , 1993 .

[21]  S. Dahlén,et al.  The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. , 1993, The European respiratory journal.

[22]  M. Kowalski,et al.  Nasal secretions in response to acetylsalicylic acid. , 1993, The Journal of allergy and clinical immunology.

[23]  S. Dahlén,et al.  Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. , 1992, The American review of respiratory disease.

[24]  F. Saulnier,et al.  Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. , 1992, The American review of respiratory disease.

[25]  T. Lee.  Mechanism of aspirin sensitivity. , 1992, The American review of respiratory disease.

[26]  A. Szczeklik,et al.  Aspirin‐induced asthma as a viral disease , 1988, Clinical allergy.

[27]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[28]  A. Szczeklik,et al.  Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. , 1975, British medical journal.

[29]  D. E. Klein,et al.  Aspirin intolerance. II. A prospective study in an atopic and normal population. , 1974, The Journal of allergy and clinical immunology.

[30]  W. Spink,et al.  Aspirin intolerance and asthma. A clinical and immunological study. , 1969, Annals of internal medicine.

[31]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.